| Literature DB >> 32236386 |
Javier Marx1, Lucrecia Acosta2, Enrique J Deschutter2, Fernando J Bornay-Llinares3, Víctor Sotillo-Soler3, José M Ramos-Rincón4.
Abstract
The aim of study was to assess the prevalence of Treponema pallidum and HIV infection in Amerindian people (Mbya Guarani) over the age of 11 in Puerto Iguazu (Argentina) and to describe the contact tracking of cases. The method was a cross-sectional study in the Mbya Guarani people living in three villages of Puerto Iguazu (community A, pop. 1,146; community B, pop. 369; and community C, pop. 149). Participants were randomly invited to participate in the survey and in blood testing. Of the 551 participants, 48 were infected by T. pallidum (8.71%; 95% confidence interval [CI] 7.38-10.04). The infection prevalence decreased with age, standing at 9.66% in the 11-19 age group, 8.42% in 20-39 age group and 4.54% in people aged 40 and older. We tracked 130 contacts for the 48 T. pallidum cases; 39/40 (97.5%) sexual contacts tested positive for syphilis. Among the 90 children born to infected mothers, 76 aged 18 months or older tested negative, while 8/14 younger children were still at risk for congenital syphilis. There were four cases of HIV infection (0.72%, 95% CI 0.31-1.13). Prevalence of T. pallidum infection and HIV infection are relevant in this indigenous community of Argentina, representing a public health concern.Entities:
Mesh:
Year: 2020 PMID: 32236386 PMCID: PMC7178811 DOI: 10.1590/S1678-9946202062019
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846
Figure 1Geographical location of the Guarani communities in Puerto Iguazu (community A, community B, and community C).
Characteristics of the Mbya Guaraní communities included in the study and the study participants.
| Characteristics | Community | ||
|---|---|---|---|
| Community A | Communiy B | Community C | |
| Total population, N | 1,146 | 369 | 149 |
| Total population aged ≥ 11 years, N (%) | 669 (58.3) | 261 (70.7) | 90 (60.4) |
| Sampling fraction, N (%) | 297 (44.4) | 176 (67.4) | 78 (86.6) |
| Median age (years) in the sample | 20 | 23 | 23 |
| Males in the sampling fraction, N (%) | 136 (45.8) | 80 (45.45) | 37 (47.4) |
| Male to female sex ratio in the study sample | 0.84 | 0.83 | 0.90 |
| Age range (years) | 11-90 | 11-84 | 11-87 |
Seroprevalence to T. pallidum and to HIV in the overall study sample and in each indigenous community.
| Total | Community A | Community B | Community C | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n/N (%) | OR (95% CI) | n/N (%) | OR (95% CI) | n/N (%) | OR (95% CI) | n/N (%) | OR (95% CI) | ||
|
| |||||||||
| Total | 48/551 (8.71) | - | 25/297 (8.42) | - | 16/176 (9.09) | - | 7/78 (8.97) | - | |
|
| |||||||||
| Male | 22/253 (8.69) | Ref | 10/136 (7.35) | Ref | 8/80 (10.00) | Ref | 4/37 (10.81) | Ref | |
| Women | 26/298 (8.72) | 1.00 (0.55-1.81) | 15/161 (9.31) | 1.29 (0.56-2.98) | 8/96 (8.33) | 0.81 (0.29-2.28) | 3/41 (7.31) | 0.65 (0.13-3.12) | |
|
| |||||||||
| 11 - 19 years | 23/238 (9.66) | Ref | 12/139 (8.63) | Ref | 7/69 (10.14) | Ref | 4/30 (13.33) | Ref | |
| 20 - 39 years | 22/247 (8.90) | 0.91 (0.49–1.68) | 11/139 (7.91) | 0.90 (0.39-2.13) | 9/77 (11.69) | 1.17 (0.41-3.33) | 2/31 (6.45) | 0.44 (0.07-2.65) | |
| ≥ 40 years | 3/66 (4.54) | 0.44 (0.12–1.53) | 2/19 (10.52) | 1.25 (0.25-6.04) | 0/30 (0.00) | NA | 1/17 (5.88) | 0.40 (0.04-3.93) | |
|
| |||||||||
| 1:2 – 1:8 | 3/48 (6.25) | - | 2/25 (8.00) | - | 1/16 (6.25) | - | 0/7 (12.50) | - | |
| 1:16 – 1:32 | 32/48 (66.66) | - | 11/25 (44.00) | - | 14/16 (87.50) | - | 7/7 (8.75) | - | |
| 1:64 – 1:128 | 13/48 (27.08) | - | 12/25 (48.00) | - | 1/16 (6.25) | - | 0/7 (0.00) | - | |
|
| |||||||||
| Total | 4/551 (0.72) | 2/297 (0.67) | 2/176 (1.13) | 0/78 (0.00) | |||||
|
| |||||||||
| Male | 1/253 (0.39) | Ref | 0/136 (0.00) | Ref | 1/80 (1.25) | Ref | 0/37 (0.00) | Ref | |
| Women | 3/298 (1.00) | 2.56 (0.26-24.8) | 2/161 (1.24) | NA | 1/96 (1.09) | 0.83 (0.05-13.5) | 0/41 (0.00) | NA | |
|
| |||||||||
| 11 - 19 years | 0/238 (0.00) | NA | 0/139 (0.00) | NA | 0/69 (0.00) | NA | 0/30 (0.00) | NA | |
| 20 - 39 years | 3/247 (1.21) | 0.79 (0.08-7.81) | 1/139 (0.71) | 0.13 (0.01-2.17) | 2/77 (2.59) | NA | 0/31 (0.00) | NA | |
| ≥ 40 years | 1/66 (1.51) | Ref | 1/19 (5.26) | Ref | 0/30 (0.00) | Ref | 0/17 (0.00) | Ref | |
n: number of events; N: sample size; NA: not available; Ref: reference; OR: odds ratio; 95% CI: confidence interval
Figure 2Flow chart of the 551 study participants and case contacts (horizontal transmission and vertical transmission).
Sexual partners from the T. pallidum seroprevalence study.
| Men | Women | Total | |
|---|---|---|---|
|
| 22 (45.9) | 26 (54.1) | 48 (100) |
| Sexual partners identified during contact tracking | 23 (57.5) | 17 (42.5) | 40 (100) |
| Positive | 22 (95.6) | 17 (100) | 39 (97.5) |
Serological follow-up of the 14 children born to mothers with T. pallidum infection.
| Patient code | Age (months) | Previous treatment for syphilis in the mother | Birthplace | VDRL titers in the mother | 1st follow-up | Treatment in the child | 2nd follow-up | 3rd follow-up (6 months) |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | No | Home | 64 | Neg | Yes | Neg | Neg |
| 2 | 3 | No | Home | 64 | 32 | Yes | 8 | 2 |
| 3 | 4 | Yes | Hosp | 32 | Neg | No | – | – |
| 4 | 1 | Yes | Hosp | 16 | Neg | No | – | – |
| 5 | 2 | No | Home | 16 | 16 | Yes | 8 | 2 |
| 6 | 4 | Yes | Hosp | 64 | Neg | No | – | – |
| 7 | 1 | Yes | Hosp | 64 | Neg | No | – | – |
| 8 | 2 | No | Home | 4 | 16 | Yes | 4 | 2 |
| 9 | 1 | No | Home | 16 | 4 | Yes | 2 | Neg |
| 10 | 1 | No | Home | 16 | 16 | Yes | 2 | Neg |
| 11 | 1 | No | Home | 8 | Neg | Yes | Neg | Neg |
| 12 | 3 | Yes | Hosp | 32 | Neg | No | – | – |
| 13 | 0 | Yes | Hosp | 64 | Neg | No | – | – |
| 14 | 1 | No | Home | 32 | 32 | Yes | 4 | 2 |
Neg: negative VDRL result; Hosp: Hospital.